Therapeutic choices in elderly diabetic patients
Lyse Bordier1, Jean Doucet2, Bernard Bauduceau1
1Service d'Endocrinologie, Hôpital Bégin, avenue de Paris, 94160 Saint-Mandé, France.
Annales D'Endocrinologie
|April 22, 2023
Summary
Caring for elderly diabetic patients is a growing public health concern. Individualized treatment, considering cardiovascular and renal protection, is crucial to balance benefits and risks, especially with insulin therapy.
Area of Science:
- Gerontology
- Public Health
- Endocrinology
Background:
- The increasing prevalence of diabetes in elderly populations presents significant public health challenges.
- Diabetic complications in older adults are often more severe and intersect with age-related health issues.
- Effective management requires addressing both diabetes and specific gerontological concerns.
Purpose of the Study:
- To highlight the public health significance of diabetes in the elderly.
- To emphasize the need for individualized treatment goals in older diabetic patients.
- To discuss the role of new therapeutic classes and insulin therapy in this demographic.
Main Methods:
- Review of current literature on elderly diabetic patient care.
- Analysis of treatment goals and therapeutic options, including new drug classes and insulin.
- Consideration of cardiovascular, renal, and gerontological factors.
Main Results:
- Newer drug classes offer cardiovascular and renal protection but require careful risk-benefit assessment.
- Insulin therapy is frequently necessary due to oral antidiabetic failure or comorbidities like renal failure.
- Patient and family education is vital for safe and effective treatment.
- Management strategies must balance avoiding undertreatment in robust elderly patients and overtreatment in fragile ones to prevent hypoglycemia.
Conclusions:
- Individualized care plans are essential for elderly diabetic patients.
- Careful consideration of new therapies and insulin is needed, balancing efficacy with risks.
- Early education and tailored management approaches are key to optimizing outcomes and minimizing hypoglycemia risk.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
322
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
322
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
242
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
242
01:26Peripheral Artery Disease IV: Nursing Management
15
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
15
01:30Heart Failure V: Medical Management
17
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
17
01:16Insulin: Dosing Regimen and Adverse Effects
219
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
219
01:27Peripheral Artery Disease III: Interprofessional Care
14
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
14